Bastide le Confort Médical - Assemblée générale mixte du 8 décembre 2020
Proxinvest relève un point de divergence notable avec le code MiddleNext : il n'existe pas de plan formalisé relativement à la succession du dirigeant. Cette préparation de la succession relevant de la responsabilité du Conseil et particulièrement de Monsieur Guy Bastide, cumulant les fonctions de Président-Directeur Général, est pourtant primordiale afin d'assurer la continuité du Groupe.
Résolution 4 : affectation du résultat.
En raison d'un endettement net important et d'une augmentation significative de celui-ci sur le dernier exercice clos, il semblerait préférable de ne pas distribuer de dividendes. Nous recommandons l'opposition.
Résolution 20 :
La rémunération de Monsieur Guy Bastide, Président-Directeur Général, s'élève à 202 809 € au titre de l’exercice 2019-2020 et représente 33% de la médiane des rémunérations totales des dirigeants des 250 premières capitalisations boursières françaises. Le montant est maîtrisé et l'absence de rémunération variable n'est pas problématique en raison de sa qualité d'actionnaire significatif. Nous recommandons l'approbation.
Résolution 21 : Transfert de la cotation des titres du marche Euronext Paris vers Euronext Growth Paris.
Le transfert réduirait les droits des actionnaires ou ferait peser un risque pour la gouvernance de la société. Ce transfert de titres ne semble donc pas favorable aux intérêts des actionnaires. Nous recommandons l'opposition.
Bastide le Confort Medical is a holding company. Through its subsidiaries, Co. is engaged in the home health care industry. Co. retails and rents medical equipment and provides medical services. Products include breathing apparatus, orthopedic shoes, walking aids and wheelchairs, home appliances and furniture adapted to the needs of the lesser able, with the recent addition of equipment related to perfusion and nutrition. Co. operates through a number of outlets concentrated mainly in the South of France, offering advice and information to customers along with the provision and maintenance of medical equipment.
Founded in 1995, Proxinvest is an independent proxy firm supporting the engagement and proxy analysis processes of investors. Proxinvest mission is to analyse corporate governance practices and resolutions proposed at general meetings of listed firms.
Proxinvest main services are :
- Proxy reports
- Definition and monitoring of client customized voting guidelines
- Corporate Governance Data and Rating
- Thematic research
- Engagement support
Proxinvest has been a pioneer and champion of good corporate governance and has grown into a recognised expert in the field.
Proxinvest is independently-owned and only works for investors : Proxinvest does not provide consulting services to the companies it covers, mitigating related risks to its clients and ensuring the independence of our analysis. As a result Proxinvest is able to take a robust, independent, engaged and unconflicted view of the companies in which our clients invest.
As Managing Partner of Expert Corprate Governance Service Ltd (ECGS), Proxinvest has built a large network of corporate governance experts to support clients in corporate governance analysis worldwide.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.